HIV / AIDS Timeline with an Emphasis on Australia &

Total Page:16

File Type:pdf, Size:1020Kb

HIV / AIDS Timeline with an Emphasis on Australia & HIV/AIDS INFORMATION LINE 150 - 154 Albion Street Surry Hills NSW 2010 Tel: +61 (2) 9332 9700 Freecall: 1800 451 600 A HIV/AIDS TIMELINE Emphasising the Australian / New South Wales Perspective The Origins of HIV/AIDS It is generally agreed that Simian Immunodeficiency Virus (SIV) found in African primates became Human Immunodeficiency Virus (HIV) which causes Acquired Immune Deficiency Syndrome (AIDS). Genotyping research, comparing different types of HIV with different types of SIV, suggests that HIV has been introduced to humans on at least 12 different occasions, once each for the 12 different types of HIV-1 and HIV-2 discovered so far. HIV-1 is divided into 4 types - Groups M (main), O (outlier), N (new or non-M/O) and P. HIV-1 Group M, is by far the most easily transmitted and widespread form of HIV found today, being responsible for more than 99% of all HIV infections worldwide and it is the form of HIV usually intended when this document just refers to HIV. HIV-1 Group M is also further divided into 9 further subtypes or clades and there are also 48 recognised recombinant forms (made up of a mix from the genome of 2 or more of the 9 clades which are most likely the result of superinfection of individuals with multiple subtypes). Countries or risk groups can have different dominant subtypes. HIV-1 Groups O, N and P only occur in small numbers of people and are rare outside of Africa. HIV-2 has 8 subtypes, 2 of the subtypes are common and are called Group A and B. The 6 additional subtypes, Groups C-H, have so far only been found in one person each. HIV-2 is more difficult to transmit, is less deadly and is generally found in older people living in West Africa, where HIV-2 has been shown to be associated with treatment by injection for tuberculosis, trypanosomiasis and sleeping sickness and with some rituals that allow the transfer of blood. The incidence of HIV-2 is falling and it has been theorised that it may eventually naturally die out. It will probably never be known exactly how, when and where HIV was transmitted to humans, but the current general consensus is: How: The Natural Transfer Theory (also Hunter, or Bushmeat, Theory) is considered by most who work in HIV research to be the simplest and most plausible explanation for the cross-species transmission of HIV, whereby researchers propose SIV was transferred to humans who hunted primates for ‘bushmeat’ via bites, cuts or other skin damage coming into contact with blood during hunting or butchering. Monkey herpes B virus, simian foamy virus and monkeypox are examples of other simian viruses that are common in people who handle monkeys and apes. Exactly how SIV evolved into HIV following infection of a hunter or bushmeat handler is still a matter of debate, although natural selection would favour any virus capable of adjusting so that it could live in, infect and reproduce using, the cells of a human host. Interestingly, the SIV most closely related to HIV-1 Group M, is itself a blend of 2 SIVs, the 1st found in red-capped mangabeys and the 2nd found in 3 other monkey species. All are monkeys that chimps hunt and eat, and the date for the transfer to, or the combination of these viruses in, chimps is estimated to be only a few hundred years before HIV was transferred to humans. When: There are many estimates of exactly when the various strains of HIV have been transferred to humans. The fact that centuries of trade in millions of African slaves introduced parasitic and viral diseases to the Caribbean and Americas did not result in an epidemic of HIV, suggests that HIV did not exist, or was extremely rare, in humans prior to the 1880s. Hunting chimpanzees, which are big and agile, became much easier with the introduction of guns, which until the 20th century were almost entirely in European hands. The most accepted estimate for the year that HIV-1 Group M was transferred to humans is considered to be around 1921 (with a margin for error of 1908-1933). Natural Transfer Theory adherents suggest that HIV was limited to very small numbers of people (less than 100) until an infected individual from the Cameroon area migrated to, or visited, the densely populated twin cities of Kinshasa/Brazzaville in the Belgian and French Congo, where other factors (discussed below) then drove expanded transmission and diversification. The estimates for the next 4 most common HIV types/groups that are transmissible between humans are: HIV-2 Group A transferred around 1932 (1906- 1955), HIV-2 Group B transferred around 1935 (1907-1961), HIV-1 Group O transferred around the year 1920 (1890-1940) and HIV-1 Group N transferred around 1963 (1948-1977). Where: Current research suggests that HIV-1 Group M, was transferred from chimpanzees to humans somewhere in what is now the Republic of Cameroon, near the borders of the Gabonese Republic and the Democratic Republic of Congo. Current research suggests that HIV-2, which is mostly restricted to West Africa, was transferred to humans from a related, but different, strain of SIV found in sooty mangabey monkeys somewhere in or around the Republic of Guinea-Bissau (type A) and the Republic of Côte d'Ivoire (Ivory Coast) (type B). It seems the other HIV subtypes were transferred at different places and times, but in similar ways from various primates, with, for example, evidence currently suggesting that HIV-1 Group O and P are more closely related to forms of SIV found in gorillas. There are other theories and factors that most likely contributed to the early and continued spread of HIV, such as: • Contaminated Needle Theory. Until the 1950s there was extensive reuse of glass syringes for immunisation against, and treatment of, many diseases in Africa. After 1956, disposable plastic syringes became available but are likely to still have been reused due to cost. In both cases, inadequately sterilised or un-sterilised equipment probably contributed to the spread of HIV from small groups where it existed for a long time into the general population. In colonial Africa, treatment of the native population was carried out for humanitarian reasons, but also to protect the native workforce and colonial administrators. Some patients are reported to have been given 300 or more injections during the colonial period. A number of studies by Dr Jacques Pépin (see October 2011) looking at elderly Africans showed large numbers with Hepatitis B & C and HTLV-1 (all blood borne viruses like HIV) and also other pathogens that are likely to have been transmitted by contaminated injecting equipment. A Facility of Prince of Wales Hospital South Eastern Sydney Local Health District - 2 - • Colonialism Theory (sometimes known as the Heart of Darkness Theory) whereby it is suggested that during the late 19th and early 20th century, when much of Africa was ruled by European colonial forces, colonial rule was particularly harsh and many people were forced into crowded labour camps and cities where people from distant tribes mixed, food was scarce (making bushmeat attractive), sanitation was poor and physical demands extreme. Colonial policy encouraged the migration of men, and discouraged the migration of women and children, to camps and cities. This led to a gender imbalance where sex work by women was tolerated or encouraged in order to keep male labourers happy. For example, in Kinshasa in 1955, there were 5.4 single men for every single woman. • Industrialisation and Urbanisation. The move of people from relatively sparse rural populations towards much more densely populated centres following industrialisation certainly increases the opportunities for risk contacts for many diseases including HIV. In Central Africa for example in 1931, only 5% of the population lived in cities. In the largest city, Kinshasa, the migration driven population went from 40,000 (1931) to 220,000 (1951) then to more than 500,000 (by 1961) when this represented a third of the entire population of the Belgian Congo. • Sexual Liberation. In the western world during the 1960s and 1970s the traditional attitudes and codes of behaviour relating to sexuality and interpersonal relationships underwent significant change. This included an increased acceptance of sex outside of traditional monogamous relationships. This may have been partially influenced by the availability of the contraceptive pill which substantially reduced the risk of pregnancy and may have led to a decrease in the heterosexual use of condoms and an increase in Sexually Transmitted Infections (STIs). In Central Africa, where HIV originated and STIs were common, sex work became de- stigmatised, as it was a way for women to gain independence and control over their own lives. In late 1950’s Kinshasa, 10% of women may have been involved in the sex trade, with an estimated 50 sex workers for every 1000 adult males. • Travel. Increased availability, affordability, popularity and speed of both national and international travel by rail, motor vehicle, ship and aeroplane over the 20th century has no doubt contributed to the spread of many infectious diseases like HIV. • Intravenous drug use. Non-medical injection of drugs grew during the 20th century. Initially the preferred route of injection by drug users was subcutaneous injection. Then between the First and Second World Wars, and especially post Vietnam, intravenous injection slowly became the preferred method. When non-medical access to injecting equipment was scarce, sharing of equipment was common. • The blood industry. The discovery of blood groups in 1901 paved the way for blood transfusion (introduced 1940s-1950s in Africa).
Recommended publications
  • Kate Fitzgerald
    In This Issue: 2020 Young Investigator Awardees pg. 3-9 In Memorium page pg. 14-15 New Member Mini-Bios pg. 19-21 Trials of Interferon Lambda pg. 31 Cytokines 2021 Hybrid Meetin pg. 24-27 Signals THE INTERNATIONAL CYTOKINE & INTERFERON SOCIETY + NEWSLETTER APRIL 2021 I VOLUME 9 I NO. 1 A NOTE FROM THE ICIS PRESIDENT Kate Fitzgerald Dear Colleagues, Greetings from the International Cytokine and Interferon Society! I hope you and your family are staying safe during these still challenging times. Thankfully 2020 is behind us now. We have lived through the COVID-19 pandemic, an event that will continue to impact our lives for some time and likely alter how we live in the future. Despite the obvious difficulties of this past year, I can’t help but marvel at the scientific advances that have been made. With everything from COVID-19 testing, to treatments and especially to the rapid pace of vaccine development, we are so better off today than even a few months back. The approval of remarkably effective COVID-19 vaccines now rolling out in the US, Israel, UK, Europe and across the globe, brings light at the end of the tunnel. The work of many of you has helped shape our understanding of the host response to Sars-CoV2 and the ability of this virus to limit antiviral immunity while simultaneously driving a cytokine driven hyperinflammatory response leading to deadly consequences for patients. The knowledge gained from all of your efforts has been put to good use to stem the threat of this deadly virus.
    [Show full text]
  • 2016 Research in Action Awards
    TREATMENT ACTION GROUP The Board of Trustees 2016 RESEARCH IN ACTION AWARDS and staff of amfAR, The Foundation Treatment Action Group’s (TAG’s) annual Research in Action Awards honor activists, scientists, philanthropists and creative artists who have made for AIDS Research extraordinary contributions in the fight against AIDS. Tonight’s awards ceremony is a fundraiser to support TAG’s programs and provides a forum for honoring heroes of the epidemic. salute the recipients of the HONOREES LEVI STRAUSS & CO. for advancing human rights and the fight 2016 TAG Research in Action Awards against HIV/AIDS ROSIE PEREZ actor/activist MARGARET RUSSELL award-winning design journalist/editor, Levi Strauss & Co. cultural leader and accomplished advocate for HIV prevention and care BARBARA HUGHES longtime AIDS activist and dedicated Rosie Perez President of TAG’s Board since 1996 HOSTS Margaret Russell JENNA WOLFE lifestyle and fitness expert BRUCE VILANCH comedy writer, songwriter, actor and Emmy ® Barbara Hughes Award winner THURSDAY, NOVEMBER 17, 2016 6PM Cocktails and Hors d’Oeuvres 7PM Awards Presentation SLATE www.amfar.org 54 West 21st Street New York City TAG ad 102716.indd 1 10/27/16 3:17 PM TAG 2016 LIMITED ART EDITION RIAA 2016 CO-CHAIRS SCOTT CAMPBELL Executive Director, Elton John AIDS Foundation DICK DADEY Executive Director, Citizens Union JOY TOMCHIN Founder of Public Square Films, Executive Producer of How to Survive a Plague and the upcoming documentary Sylvia and Marsha RIAA 2016 HONORARY CHAIRS 2014 RIAA honoree ALAN CUMMING and GRANT SHAFFER 2009 RIAA honoree DAVID HYDE PIERCE and BRIAN HARGROVE ROSALIND FOX SOLOMON Animal Landscape, 1979 Archival pigment print | 15 1/2 x 15 1/2 inches | 8-ply mat + granite welded metal frame + uv plexi 23 1/2 x 23 inches | Edition of 15 + 3 AP's | ©Rosalind Fox Solomon, www.rosalindsolomon.com RIAA 2016 COMMITTEE Courtesy of Bruce Silverstein Gallery Joy Episalla, Chair for Projects Plus, Inc.
    [Show full text]
  • Abortion, Homosexuality and the Slippery Slope: Legislating ‘Moral’ Behaviour in South Australia
    Abortion, Homosexuality and the Slippery Slope: Legislating ‘Moral’ Behaviour in South Australia Clare Parker BMusSt, BA(Hons) A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy, Discipline of History, Faculty of Humanities and Social Sciences, University of Adelaide. August 2013 ii Contents Contents ii Abstract iv Declaration vi Acknowledgements vii List of Abbreviations ix List of Figures x A Note on Terms xi Introduction 1 Chapter 1: ‘The Practice of Sound Morality’ 21 Policing Abortion and Homosexuality 24 Public Conversation 36 The Wowser State 44 Chapter 2: A Path to Abortion Law Reform 56 The 1930s: Doctors, Court Cases and Activism 57 World War II 65 The Effects of Thalidomide 70 Reform in Britain: A Seven Month Catalyst for South Australia 79 Chapter 3: The Abortion Debates 87 The Medical Profession 90 The Churches 94 Activism 102 Public Opinion and the Media 112 The Parliamentary Debates 118 Voting Patterns 129 iii Chapter 4: A Path to Homosexual Law Reform 139 Professional Publications and Prohibited Literature 140 Homosexual Visibility in Australia 150 The Death of Dr Duncan 160 Chapter 5: The Homosexuality Debates 166 Activism 167 The Churches and the Medical Profession 179 The Media and Public Opinion 185 The Parliamentary Debates 190 1973 to 1975 206 Conclusion 211 Moral Law Reform and the Public Interest 211 Progressive Reform in South Australia 220 The Slippery Slope 230 Bibliography 232 iv Abstract This thesis examines the circumstances that permitted South Australia’s pioneering legalisation of abortion and male homosexual acts in 1969 and 1972. It asks how and why, at that time in South Australian history, the state’s parliament was willing and able to relax controls over behaviours that were traditionally considered immoral.
    [Show full text]
  • 2Nd International Conference on Flu October 31-November 02, 2016 San Francisco, USA
    Donald P Francis, Virol Mycol 2016, 5:3(Suppl) conferenceseries.com http://dx.doi.org/10.4172/2161-0517.C1.013 2nd International Conference on Flu October 31-November 02, 2016 San Francisco, USA Donald P Francis Global Solutions for Infectious Diseases, USA WHO technology transfer activities for influenza vaccines he World Health Organization states that, “Though the world is better prepared for the next pandemic than ever before, Tit remains highly vulnerable, especially to a pandemic that causes severe disease. Nothing about influenza is predictable, including where the next pandemic might emerge and which virus might be responsible.” WHO’s preparations to minimize the impact of influenza virus related disease cover a wide variety of activities that include surveillance of circulating viruses (in both birds and humans), supplying current circulating virus reagents for clinical diagnosis of cases, efforts to expand influenza vaccine production in lower and middle income countries and collaboration and support of trials to evaluate vaccines in people. The surveillance efforts are essential to identifying circulating viruses so subsequent control activities can be matched to the strain and clinical severity of the disease. In 2014, 142 laboratories in 112 countries joined together in what is known as the Global Influenza Surveillance and Response System. The laboratories in that system tested more than 1.9 million clinical specimens. To speed the diagnostic capabilities for this rapidly changing infection, WHO supplies reagents capable of identifying the latest circulating viruses; for example for the 2009 when the H1N1 outbreak was declared a public health emergency, WHO shipped out diagnostic reagents to laboratories within seven days.
    [Show full text]
  • Maria Khan, Matthew Epperson, Disconnetted
    positivelyaware.com MAY+JUNE 2012 TWo EPIDEMICS IncarceratIon and HIV How the criminal justice system can play an effective role in the treatment and prevention of HIV ThE benefiTs of opT-out tesTiNg risk fAcTors for women coNfErencE Update: croi B:16.5 in T:16 in S:15 in www.egrifta.com YOU’VE WORKED TO CONTROL YOUR HIV. NOW, TIME TO WORK ON YOUR FILE NAME 0053_EGR_AD_SPD_ HIV-RELATED EXCESS BELLY FAT. PA_May_August_ In two separate clinical trials of HIV-infected people with lipodystrophy, each lasting 6 months, EGRIFTA® (tesamorelin M3.inddDATE 03.30.12 for injection) reduced HIV-related excess belly fat by an average of 18% in the rst trial, and 14% in the second trial. CLIENT This reduction in excess belly fat resulted in an approximate 1-inch reduction in waist size. Individual results may vary. On ® Egrifta average, patients on EGRIFTA did not lose weight. PART # Like HIV, HIV-related excess belly fat is a chronic condition. In clinical studies: 120127-102148 • People who used EGRIFTA® continuously for 1 year maintained their results over this time period DESCRIPTION • People who stopped taking EGRIFTA® after 6 months had their HIV-related excess belly fat come back EGRIFTA® is believed to work with your own body to produce natural growth hormone to reduce your excess belly fat. Print Ad Positively Aware - Spread SPECS Indication: EGRIFTA® is a daily injectable prescription medicine to reduce the excess abdominal fat in HIV-infected patients with lipodystrophy. Trim: 16 x 10.5” Limitations of use: Bleed: 16.5 x 11” • The impact and safety of EGRIFTA® on cardiovascular health has not been studied Safety: 15 x 9.5” • EGRIFTA® is not indicated for weight-loss management Gutter: 1” • It’s not known whether taking EGRIFTA® helps improve compliance with antiretroviral medications Colors: 4C, CMYK • EGRIFTA® is not recommended to be used in children COLOR INFO Important Risk Information • Injection-site reactions, such as redness, itching, pain, irritation, T:10.5 in T:10.5 S:9.5 in Do not use EGRIFTA® if you: bleeding, rash, and swelling.
    [Show full text]
  • Frequency and Implications of HIV Superinfection
    Review Frequency and implications of HIV superinfection Andrew D Redd, Thomas C Quinn, Aaron A R Tobian* HIV superinfection occurs when an individual with HIV is infected with a new distinct HIV viral strain. Superinfection Published Online has been reported throughout the world, and studies have recorded incidence rates of 0–7∙7% per year. Use of next- May 31, 2013 generation sequencing has improved detection of superinfection, which can be transmitted by injecting drug use and http://dx.doi.org/10.1016/ S1473-3099(13)70066-5 sexual intercourse. Superinfection might have incidence rates comparable to those of initial HIV infection. Clinicians Division of Intramural should encourage safe sexual and injecting drug use practices for HIV-infected patients because superinfection has Research, National Institute of detrimental eff ects on clinical outcomes and could pose a concern for large-scale antiretroviral treatment plans. The Allergy and Infectious Diseases, occurrence of superinfection has implications for vaccine research, since it seems initial HIV infection is not fully National Institutes of Health, protective against a subsequent infection. Additional collaborative research could benefi t care of patients and inform Bethesda, MD, USA (A D Redd PhD, future vaccine design. Prof T C Quinn MD); Department of Pathology, Introduction Detection of HIV superinfection School of Medicine, Johns HIV superinfection occurs when an individual with The investigators in initial studies that identifi ed indi- Hopkins University, Baltimore, MD (A A R Tobian MD) HIV becomes infected with a new, phylogenetically distinct viduals dually infected with HIV-1 and HIV-2 used Correspondence to: viral HIV strain.
    [Show full text]
  • Individual Responsibility Concerning HIV
    SIT Graduate Institute/SIT Study Abroad SIT Digital Collections Independent Study Project (ISP) Collection SIT Study Abroad Fall 2006 Individual Responsibility Concerning HIV Transmission Among MSM: A Comparative Study of the Effectiveness of NGO Intervention Policies and Their rP actical Applications Within the United Kingdom, Australia, and the Netherlands Martha Kienbaum SIT Study Abroad Follow this and additional works at: https://digitalcollections.sit.edu/isp_collection Part of the Mass Communication Commons, and the Public Health Education and Promotion Commons Recommended Citation Kienbaum, Martha, "Individual Responsibility Concerning HIV Transmission Among MSM: A Comparative Study of the Effectiveness of NGO Intervention Policies and Their rP actical Applications Within the United Kingdom, Australia, and the Netherlands" (2006). Independent Study Project (ISP) Collection. 290. https://digitalcollections.sit.edu/isp_collection/290 This Unpublished Paper is brought to you for free and open access by the SIT Study Abroad at SIT Digital Collections. It has been accepted for inclusion in Independent Study Project (ISP) Collection by an authorized administrator of SIT Digital Collections. For more information, please contact [email protected]. Individual Responsibility Concerning HIV Transmission Among MSM: A comparative study of the effectiveness of NGO intervention policies and their practical applications within the United Kingdom, Australia, and the Netherlands “We need to break the silence, banish the stigma and discrimination and ensure total inclusiveness within the struggle against AIDS.” Nelson Mandela Martha Kienbaum Fall 2006 School for International Training Amsterdam Project Advisor: Tobias Dörfler Academic Advisor: Ginni Fleck 1 Abstract This study investigates the complexities involved in utilizing the terms of individual responsibility for the construction of HIV prevention campaigns that target men who have sex with men.
    [Show full text]
  • Marketing Safe Sex: the Politics of Sexuality, Race and Class in San Francisco, 1983 - 1991
    Marketing Safe Sex: The Politics of Sexuality, Race and Class in San Francisco, 1983 - 1991 Jennifer Brier Great Cities Institute College of Urban Planning and Public Affairs University of Illinois at Chicago Great Cities Institute Publication Number: GCP-06-06 A Great Cities Institute Working Paper May 2006 The Great Cities Institute The Great Cities Institute is an interdisciplinary, applied urban research unit within the College of Urban Planning and Public Affairs at the University of Illinois at Chicago (UIC). Its mission is to create, disseminate, and apply interdisciplinary knowledge on urban areas. Faculty from UIC and elsewhere work collaboratively on urban issues through interdisciplinary research, outreach and education projects. About the Author Jennifer Brier is Assistant Professor of Gender and Women’s Studies and History in the College of Liberal Arts and Sciences at the University of Illinois at Chicago. She was a GCI Faculty Scholar during the 2005 – 2006 academic year. She may be reached at [email protected]. Great Cities Institute Publication Number: GCP-06-06 The views expressed in this report represent those of the author(s) and not necessarily those of the Great Cities Institute or the University of Illinois at Chicago. This is a working paper that represents research in progress. Inclusion here does not preclude final preparation for publication elsewhere. Great Cities Institute (MC 107) College of Urban Planning and Public Affairs University of Illinois at Chicago 412 S. Peoria Street, Suite 400 Chicago IL 60607-7067
    [Show full text]
  • Coevolution of HIV-1 and Broadly Neutralizing Antibodies
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Curr Opin Manuscript Author HIV AIDS. Author Manuscript Author manuscript; available in PMC 2020 October 13. Published in final edited form as: Curr Opin HIV AIDS. 2019 July ; 14(4): 286–293. doi:10.1097/COH.0000000000000550. Coevolution of HIV-1 and broadly neutralizing antibodies Nicole A. Doria-Rosea, Elise Landaisb aVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland bIAVI Neutralizing Antibody Center, Immunology and Microbiology Department, The Scripps Research Institute, La Jolla, California, USA Abstract Purpose of review—Exploring the molecular details of the coevolution of HIV-1 Envelope with broadly neutralizing antibodies (bNAbs) in infected individuals over time provides insights for vaccine design. Since mid-2017, the number of individuals described in such publications has nearly tripled. New publications have extended such studies to new epitopes on Env and provided more detail on previously known sites. Recent findings—Studies of two donors – one of them an infant, the other with three lineages targeting the same site – has deepened our understanding of V3-glycan-directed lineages. A V2- apex-directed lineage showed remarkable similarity to a lineage from a previously described donor, revealing general principles for this class of bNAbs. Understanding development of CD4 binding site antibodies has been enriched by the study of a VRC01-class lineage. Finally, the membrane-proximal external region is a new addition to the set of epitopes studied in this manner, with early development events explored in a study of three lineages from a single donor.
    [Show full text]
  • Demetre C Daskalakis MD
    Demetre C Daskalakis MD MPH New York City Department of Health and Mental Hygiene 42-09 28th Street, Long Island City, NY 11101 Cell: 347-989-5513 Office: 347-396-7728 [email protected] EDUCATION Degree Programs: 2012 Harvard School of Public Health Boston, MA Masters of Public Health 1999 NYU School of Medicine New York, NY Medical Doctor 1995 Columbia University New York, NY Bachelor of Arts Post-Graduate Medical Training: 1999-2002 Harvard- Beth Israel Deaconess Boston, MA Residency (Medicine) 2002-2003 Harvard- Beth Israel Deaconess Boston, MA Chief Residency 2003-2005 Harvard-Partners Healthcare Boston, MA Fellowship (Infectious Dis) PROFESSIONAL EXPERIENCE 2017-Current New York City Department of Health and Mental Hygiene Deputy Commissioner- Division of Disease Control Oversee all infectious disease related public health programming at the NYC Department of Health, including: . Bureau of HIV . Bureau of Sexually Transmitted Infections . Bureau of Tuberculosis . Bureau of Communicable Diseases (Including Viral Hepatitis) . Public Health Laboratory . Bureau of Immunization . Bureau of Administration Over 1000 employees, 13 direct service clinical sites Oversee budget of nearly $300,000,000 Notable experience: o Coordinated response to local Legionella Clusters including coordination of epidemiology, environmental health, and lab responses including clusters related to cooling towers in Lenox Hill, Flushing, and Upper Washington Heights o Re-established funding for Tuberculosis Clinics and Field Services after drastic
    [Show full text]
  • ACT up by Geoffrey W
    ACT UP by Geoffrey W. Bateman Encyclopedia Copyright © 2015, glbtq, Inc. Entry Copyright © 2004, glbtq, inc. Reprinted from http://www.glbtq.com On March 24, 1987, the AIDS Coalition To Unleash Power, or ACT UP, staged its first action in New York City on Wall Street, protesting the Food and Drug Administration and the drug company Burroughs Wellcome. Converging on the site in the hundreds, protesters passed out flyers, disrupted traffic, and drew considerable media attention. One activist even built an effigy of the head of the FDA that he hung outside a church during the protest. Through this demonstration, ACT UP initiated its direct-action strategy in the fight against the AIDS epidemic. Using bold images and confrontational tactics, ACT UP worked to promote awareness of AIDS and challenge the complacency of politicians and government officials who had yet to respond adequately to the crisis. As its statement of purpose reads, "ACT UP is a diverse, non-partisan group united in anger and committed to direct action to end the AIDS crisis. We protest and demonstrate; we meet with government and public health officials; we research and distribute the latest medical information; we are not silent." Targeting Wall Street allowed ACT UP to highlight one of the most pressing needs of those living with AIDS in the late 1980s--effective and affordable drug treatment. Because of FDA policies, Burroughs Wellcome was the only company that made and sold AZT. The high cost of the drug--anywhere from $10,000 to $13,000 a year for one patient--and the belief that it was the only treatment option available prompted New York City activists to target this monopoly.
    [Show full text]
  • Françoise Barré-Sinoussi : L’Engagement D’Une Vie
    5 euros – septembre/octobre 2015 – n°79 Françoise Barré-Sinoussi : l’engagement d’une vie magazine d’information sur le sida agenda 2015 Concours VIH Pocket Films 2015/2016 Sidaction lance la 3e édition du concours VIH Pocket Films en octobre 2015. Cet événement s’adresse aux jeunes de 15 à 25 ans et les invite à réaliser une vidéo de deux minutes sur le VIH à partir de leurs téléphones portables. LES CHEFS Le concours reçoit le soutien des ministères de l’Éducation nationale, de l’Enseignement supérieur et de la Recherche ; de l’Agriculture, SOLIDAIRES de l’Agroalimentaire et de la Forêt ; de la Ville, de la Jeunesse et des Sports ; de la Culture et JEUDI 8 OCTOBRE 2015 de la Communication ; des Affaires sociales, de la Santé et des Droits des femmes, et de la VOtRE REStAuRAtEuR Justice. SE mObILISE pOuR LA LuttE COntRE LE sida Plus d’informations : www.sidaction.org/concours-vih-pocket-films pour être solidaire, mettez les pieds sous la table, 5 novembre 10% DE LA RECEttE nous nous occupons du reste ! SEROnt REVERSéS Colloque : « Adolescent, jeune majeur : à SidactIOn vivre avec une maladie chronique » Organisé par Dessine-moi un mouton de 8 h 30 à 17 h 30 Centre de séminaires de l’institut Image 24, boulevard de Montparnasse 75015 Paris Entrée libre dans la limite des places disponibles. Inscription préalable obligatoire : [email protected] Retrouver la liste des restaurants participants sur notre site : www.sidaction.org ou au +33 (0)1 40 28 14 35 Du 19 au 22 novembre 8 octobre Le Salon de l’éducation 7e édition des Chefs solidaires À l’occasion du Salon européen de l’éducation, Durant cette journée, des restaurateurs reversent 10 % de leur recette du jour à Sidaction.
    [Show full text]